The Impact of Early Norepinephrine Administration on Outcomes of Patients With Sepsis-induced Hypotension
Norepinephrine, Sepsis, Hypotension
About this trial
This is an interventional treatment trial for Norepinephrine
Eligibility Criteria
Inclusion Criteria: Adult patients aged from18 to 65 years old had the diagnostic criteria for sepsis as the presence of infection systemic manifestations of infection and signs of Hypoperfusion Exclusion Criteria: Acute cerebral vascular event Active cardiac conditions Valvular heart diseases Hypotension suspected to be due to another cause and comorbidities Status asthmatics Active hemorrhage Pregnancy Burn injury Requirement for immediate surgery Advanced-stage cancer Refusal to participate in the study
Sites / Locations
- Faculty of medicine, Tanta university
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
A
B
patients received (30ml /kg) ringer's lactate solution after first presentation then norepinephrine was added when persistent mean arterial pressure (MAP)> 65 mmHg despite adequate fluid resuscitation
patients received ( 30ml /kg) ringer's lactate solution after first presentation combined with norepinephrine infusion (0.05 mic/kg/min)